Current share price for NVU : $0.050 0.003 (5.66%)+
Nanoveu Limited (NVU), an ASX-listed company, is a technology company developing a range of products for mobile phones and other digital displays. The Company's wholly-owned, flagship product is its Nanoshield antiviral protection which is available in a variety of mobile phone screen covers, mobile phone cases and as a commercial film capable of being applied to a number of surfaces. The product is a clear plastic containing a layer of charged copper nanoparticles which have antiviral and antimicrobial properties.
| ASX Code | NVU |
| Website | http://www.nanoveu.com |
| Industry/Sector | Electronic Components |
| Market Cap ($M) | 54 |
| NVU Share Price | $0.050 |
| Day High | $0.053 |
| Day Low | $0.050 |
| Last Close | $0.053 |
| NVU Share Price Movement | $0.00 ( 5.66% ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Nanoveu Limited (NVU) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Dec | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$7.60 | -$0.90 | 52.50% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$2.85 | -$0.60 | 1.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$2.16 | -$0.60 | -47.80% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Nanoveu Limited (NVU) | $61M | 0.5254 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 4.24 | 0.00 |
| Market | 0.30 | 13.20 | 1.17 | 0.66 |
| Sector | 1.45 | 45.30 | 1.72 | 1.47 |
| Name | Position | Start Date |
|---|---|---|
| Dr David Pevcic | Executive Chairman, Executive Director | 3 Feb 2023 |
| Mr Teck Eng (Alfred) Chong | Founder, Chief Executive Officer, Managing Director | 14 Feb 2018 |
| Mr Steven James Apedaile | Non-Executive Director | 14 May 2018 |
| Mr Siyuan (Raymond) Chen | Non-Executive Director | 1 Dec 2025 |
| Professor Mohamed Sabry Aly | Non-Executive Director | 1 Dec 2025 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 7 Aug 2025 | PEVCIC, David | Issued | Indirect Shares | 12,903,226 | $0.031 | $400,000.000 |
| 15 Jun 2025 | CHONG, Teck Eng (Alfred) | Issued | Direct Shares | 96,154 | $0.040 | $3,846.160 |
| 15 Jun 2025 | CHONG, Teck Eng (Alfred) | Exercise | Options | 96,154 | $0.040 | $3,846.160 |
See all changes in directors' interest & trades for Nanoveu Limited (NVU) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Siyuan (Raymond) Chen | Chief Financial Officer |
| Harry Spindler | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Nanoveu Limited (NVU). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 58,218,973 (5.39%) | David Dominic Pevcic |
| Date | Event |
|---|---|
| 26 February 2027 | Report (Annual) |
| 28 August 2026 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.